常染色体显性多囊肾病中磁共振胰胆管成像所见胆总管扩张
该回顾性研究测量254例常染色体显性多囊肾病(ADPKD)患者与254例年龄性别匹配的非ADPKD对照者的胆总管直径,发现ADPKD组胆总管中位直径较对照组大22%,且更容易出现无胆道梗阻的胆总管扩张≥10 mm;作者认为认识这一关联可减少不必要的诊断检查。
要点
- ADPKD患者胆总管中位直径较对照大22%(5.6 mm vs 4.6 mm),且扩张≥10 mm者比例更高。
- ADPKD患者胆总管扩张可无胆道梗阻,阅片时需结合临床避免误判为梗阻性病变。
- PKD1或PKD2突变与年龄与胆总管直径增大相关,血清白蛋白与胆总管直径减小相关。
核心结论
- ADPKD患者胆总管直径较非ADPKD对照大22%,且更常出现无胆道梗阻的胆总管扩张≥10 mm;认识这一关联可能减少不必要的诊断检查。
研究设计与样本
- 回顾性研究,纳入ADPKD患者254例及年龄性别匹配的非ADPKD对照254例,均行腹部MRI,在T2加权图像上测量胆总管直径并与临床、实验室及MRI特征(包括器官体积和囊肿负荷)进行相关分析。
关键影像表现/征象
- ADPKD组胆总管中位直径5.6 mm(四分位距4.7–6.9 mm),对照组4.6 mm(四分位距3.9–5.4 mm)。
- ADPKD组13例(5.1%)胆总管直径≥10 mm,对照组1例(0.4%)胆总管直径≥10 mm。
- 胆总管直径测量的观察者间一致性极佳(组内相关系数=0.92)。
诊断标准与关键数值
- 胆总管直径在T2加权MRI上测量,ADPKD组中位直径较对照组大22%(5.6 mm vs 4.6 mm,p<0.001)。
- ADPKD组胆总管直径≥10 mm者13例(5.1%),对照组1例(0.4%)(p<0.001)。
- 多变量分析显示PKD1或PKD2突变(beta=1.5,P<0.001)和年龄(beta=0.04,p<0.001)与胆总管直径增大相关,血清白蛋白与胆总管直径减小相关(beta=-0.39,p<0.001)。
临床应用与阅片要点
- ADPKD患者胆总管直径可较非ADPKD者更大,且可在无胆道梗阻情况下出现≥10 mm的扩张,阅片时应结合临床避免将其误判为梗阻性病变。
- 作者认为认识非梗阻性胆总管扩张与ADPKD的关联可能减少不必要的诊断检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Polycystic liver disease is the most prevalent extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). Non-obstructive asymptomatic common bile duct (CBD) dilatation has been observed anecdotally on CT scans, but CT is not optimal for biliary visualization. Here, we measured CBD diameter on T2-weighted MRI in ADPKD subjects to determine if CBD dilatation is associated with ADPKD.
METHODS: CBD diameter was measured retrospectively on ADPKD subjects (n = 254) and on age- and sex-matched controls without ADPKD (n = 254) who underwent abdominal MRI. CBD diameter in these groups was compared and correlated with clinical, laboratory and magnetic resonance imaging (MRI) features, including organ volumes and cyst burden.
RESULTS: CBD median diameter [interquartile range, IQR, 25%, 75%] was 22% larger in ADPKD compared to controls (5.6 [4.7, 6.9] mm vs. 4.6 [3.9, 5.4] mm, p < 0.001). CBD diameter measurements had excellent inter-observer agreement (Intraclass correlation coefficient = 0.92). Thirteen (5.1%) ADPKD subjects had a CBD diameter ≥ 10 mm compared to 1 (0.4%) control subject (p < 0.001). Multivariable analysis found the presence of PKD1 or PKD2 mutation (beta = 1.5, P < 0.001) and age (beta = 0.04, p < 0.001) to be associated with increased CBD diameter and serum albumin associated with decreased CBD diameter (beta=-0.39, p < 0.001).
CONCLUSION: ADPKD subjects had 22% larger CBD diameters than in non-ADPKD controls and were more likely to have CBD dilatation ≥ 10 mm without CBD obstruction. Awareness of this association of non-obstructive CBD dilatation with ADPKD may limit unnecessary diagnostic testing.
引用
- Sattar U, Zhu C, Yin X, et al. Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease. Abdom Radiol (NY). 2025. PMID: 40676196. doi:10.1007/s00261-025-05122-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。